207 related articles for article (PubMed ID: 19143565)
41. Inactive forms of the catalytic subunit of protein kinase A are expressed in the brain of higher primates.
Larsen AC; Kvissel AK; Hafte TT; Avellan CI; Eikvar S; Rootwelt T; Ørstavik S; Skålhegg BS
FEBS J; 2008 Jan; 275(2):250-62. PubMed ID: 18070107
[TBL] [Abstract][Full Text] [Related]
42. E230Q mutation of the catalytic subunit of cAMP-dependent protein kinase affects local structure and the binding of peptide inhibitor.
Ung MU; Lu B; McCammon JA
Biopolymers; 2006 Apr; 81(6):428-39. PubMed ID: 16365849
[TBL] [Abstract][Full Text] [Related]
43. ATP-conjugated peptide inhibitors for calmodulin-dependent protein kinase II.
Ahn DR; Han KC; Kwon HS; Yang EG
Bioorg Med Chem Lett; 2007 Jan; 17(1):147-51. PubMed ID: 17035012
[TBL] [Abstract][Full Text] [Related]
44. Backbone flexibility of five sites on the catalytic subunit of cAMP-dependent protein kinase in the open and closed conformations.
Gangal M; Cox S; Lew J; Clifford T; Garrod SM; Aschbaher M; Taylor SS; Johnson DA
Biochemistry; 1998 Sep; 37(39):13728-35. PubMed ID: 9753461
[TBL] [Abstract][Full Text] [Related]
45. Dissecting the determinants of cyclin-dependent kinase 2 and cyclin-dependent kinase 4 inhibitor selectivity.
Pratt DJ; Bentley J; Jewsbury P; Boyle FT; Endicott JA; Noble ME
J Med Chem; 2006 Sep; 49(18):5470-7. PubMed ID: 16942020
[TBL] [Abstract][Full Text] [Related]
46. MgATP-induced conformational change of the catalytic subunit of cAMP-dependent protein kinase.
Yang S; Rogers KM; Johnson DA
Biophys Chem; 2005 Feb; 113(2):193-9. PubMed ID: 15617827
[TBL] [Abstract][Full Text] [Related]
47. Molecular characterisation of cAMP-dependent protein kinase (PK-A) catalytic subunit isoforms in the male tick, Amblyomma hebraeum.
Tabish M; Clegg RA; Turner PC; Jonczy J; Rees HH; Fisher MJ
Mol Biochem Parasitol; 2006 Dec; 150(2):330-9. PubMed ID: 17049629
[TBL] [Abstract][Full Text] [Related]
48. Structural determinants of phosphodiesterase 6 response on binding catalytic site inhibitors.
Simon A; Barabás P; Kardos J
Neurochem Int; 2006 Aug; 49(3):215-22. PubMed ID: 16519963
[TBL] [Abstract][Full Text] [Related]
49. Determinants of ligand binding to cAMP-dependent protein kinase.
Hünenberger PH; Helms V; Narayana N; Taylor SS; McCammon JA
Biochemistry; 1999 Feb; 38(8):2358-66. PubMed ID: 10029529
[TBL] [Abstract][Full Text] [Related]
50. The catalytic subunit of human protein kinase CK2 structurally deviates from its maize homologue in complex with the nucleotide competitive inhibitor emodin.
Raaf J; Klopffleisch K; Issinger OG; Niefind K
J Mol Biol; 2008 Mar; 377(1):1-8. PubMed ID: 18242640
[TBL] [Abstract][Full Text] [Related]
51. Microarray-based kinase inhibition assay by gold nanoparticle probes.
Sun L; Liu D; Wang Z
Anal Chem; 2007 Jan; 79(2):773-7. PubMed ID: 17222050
[TBL] [Abstract][Full Text] [Related]
52. Development of a peptide inhibitor-based cantilever sensor assay for cyclic adenosine monophosphate-dependent protein kinase.
Kwon HS; Han KC; Hwang KS; Lee JH; Kim TS; Yoon DS; Yang EG
Anal Chim Acta; 2007 Mar; 585(2):344-9. PubMed ID: 17386684
[TBL] [Abstract][Full Text] [Related]
53. Rapid generation of a high quality lead for transforming growth factor-beta (TGF-beta) type I receptor (ALK5).
Goldberg FW; Ward RA; Powell SJ; Debreczeni JE; Norman RA; Roberts NJ; Dishington AP; Gingell HJ; Wickson KF; Roberts AL
J Med Chem; 2009 Dec; 52(23):7901-5. PubMed ID: 19736928
[TBL] [Abstract][Full Text] [Related]
54. Computational analyses of JAK1 kinase domain: subtle changes in the catalytic cleft influence inhibitor specificity.
Zhang X; Hu Y; Yuan Z
Biochem Biophys Res Commun; 2008 May; 370(1):72-6. PubMed ID: 18346458
[TBL] [Abstract][Full Text] [Related]
55. Efficacy of the phosphorylation of synthetic peptides by purified catalytic subunit of PKA (PKAcat) from bovine lens depends on the amino acid sequence of the peptides.
Samanta B; Mezö G; Das KP; Ghose AC; Hudecz F; Sen PC
J Pept Res; 2005 Apr; 65(4):445-9. PubMed ID: 15813892
[TBL] [Abstract][Full Text] [Related]
56. A novel activating effect of the regulatory subunit of protein kinase A on catalytic subunit activity.
Rinaldi J; Ocampo J; Rossi S; Moreno S
Arch Biochem Biophys; 2008 Dec; 480(2):95-103. PubMed ID: 18854166
[TBL] [Abstract][Full Text] [Related]
57. Single-molecule observation of the catalytic subunit of cAMP-dependent protein kinase binding to an inhibitor peptide.
Xie H; Braha O; Gu LQ; Cheley S; Bayley H
Chem Biol; 2005 Jan; 12(1):109-20. PubMed ID: 15664520
[TBL] [Abstract][Full Text] [Related]
58. Insights for the development of specific kinase inhibitors by targeted structural genomics.
Fedorov O; Sundström M; Marsden B; Knapp S
Drug Discov Today; 2007 May; 12(9-10):365-72. PubMed ID: 17467572
[TBL] [Abstract][Full Text] [Related]
59. Structural bioinformatics-based prediction of exceptional selectivity of p38 MAP kinase inhibitor PH-797804.
Xing L; Shieh HS; Selness SR; Devraj RV; Walker JK; Devadas B; Hope HR; Compton RP; Schindler JF; Hirsch JL; Benson AG; Kurumbail RG; Stegeman RA; Williams JM; Broadus RM; Walden Z; Monahan JB
Biochemistry; 2009 Jul; 48(27):6402-11. PubMed ID: 19496616
[TBL] [Abstract][Full Text] [Related]
60. Effect of metal ions on high-affinity binding of pseudosubstrate inhibitors to PKA.
Zimmermann B; Schweinsberg S; Drewianka S; Herberg FW
Biochem J; 2008 Jul; 413(1):93-101. PubMed ID: 18373497
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
